This site is intended for healthcare professionals only
LoginRegister
Zydus Asked to Revise Phase III Trial Protocol for Cough Syrup FDC After CDSCO Panel ReviewCDSCO Panel suggests revising phase III CT protocol of Zydus Healthcare's Empagliflozin plus...
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIAConduct BE study or present safety data: CDSCO Panel tells IQVIA on anti-cancer Drug Daratumumab...
Shilpa Medicare Unit VI Bengaluru facilityUSFDA concludes inspection at Shilpa Medicare Raichur unit
Alkem Labs Adil Billimoria steps downUSFDA inspection: Alkem Labs concludes inspection at Taloja Center
JB Chemicals Panoli facility concludes USFDA inspection no observationsJB Chemicals and Pharma Panoli facility concludes USFDA inspection no observations
USFDA inspectionUSFDA concludes inspection at Zydus Lifesciences Ankleshwar facility
1471 drugs samples manufactured in HP failed quality tests in past two years: Minister1471 drugs samples manufactured in HP failed quality tests in past two years: Minister
Windlas Biotech Gets SEC Nod to Manufacture Dapagliflozin-Pioglitazone FDCModify Phase III CT protocol: CDSCO panel Tells Windlas Biotech on FDC Tamsulosin plus Mirabegron
Synokem Pharmaceutical Gets CDSCO Panel Nod To Study Anti-rheumatoid drug IguratimodSynokem Pharmaceutical Gets CDSCO Panel Nod To Study Anti-rheumatoid drug Iguratimod
Cardiac, GI Power Indian Pharma Markets 7.5% March SurgeIndian Pharma Market Grows 7.5% in Feb 2025, But Respiratory Segment Declines by 4.6%
Novo Nordisk Appoints Mike Doustdar as New CEO Amid Executive ReshuffleCagriSema demonstrates superior weight loss in adults with obesity, type 2 diabetes in REDEFINE 2...
No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in IndiaRoche, Zealand Pharma ink pact to co-develop, co-commercialise petrelintide as foundational therapy...
X